Our strategy is to research and produce innovative, high-quality and needed medicines; making these as accessible as possible ... to countries at all levels of income and development. To do this we focus on creating a strong differentiated pipeline, leading in HIV and respiratory, and developing our presence in speciality therapy areas, including oncology and immuno-inflammation. read more